Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low molecular weight heparin gel plus ultra-pulsed CO2 fractional laser for acne scars
ChiCTR2200061274Phase 4Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of heparin in acne scar (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Goodman & Baron acne scar grading system score. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
acne scar
Beyond the preview
Go deeper on ChiCTR2200061274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061274.